BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15158664)

  • 1. Polyagglutination NOR: new glycosphingolipid antigens recognized by a new type of common human anti-alpha-galactosyl antibodies.
    Lisowska E; Duk M
    Arch Biochem Biophys; 2004 Jun; 426(2):142-7. PubMed ID: 15158664
    [No Abstract]   [Full Text] [Related]  

  • 2. Specificity of human anti-NOR antibodies, a distinct species of "natural" anti-alpha-galactosyl antibodies.
    Duk M; Westerlind U; Norberg T; Pazynina G; Bovin NN; Lisowska E
    Glycobiology; 2003 Apr; 13(4):279-84. PubMed ID: 12626386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glycosphingolipids of blood groups. Their value in biochemical immunogenetics].
    Salmon C; Cartron JP; Doinel C; Lopez M; Badet J; Ropars C; Mulet C
    Expos Annu Biochim Med; 1980; 34():119-49. PubMed ID: 7009201
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-alpha-galactosyl antibodies recognizing epitopes terminating with alpha1,4-linked galactose: human natural and mouse monoclonal anti-NOR and anti-P1 antibodies.
    Duk M; Kusnierz-Alejska G; Korchagina EY; Bovin NV; Bochenek S; Lisowska E
    Glycobiology; 2005 Feb; 15(2):109-18. PubMed ID: 15342552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red blood cell antigens responsible for inherited types of polyagglutination.
    Lisowska E; Duk M
    Adv Exp Med Biol; 2001; 491():141-53. PubMed ID: 14533796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
    Galili U
    Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralization of blood group A-antigen by a novel anti-A antibody: overcoming ABO-incompatible solid-organ transplantation.
    Hasegawa Y; Kato Y; Kaneko MK; Ogasawara S; Shimazu M; Tanabe M; Kawachi S; Obara H; Shinoda M; Kitagawa Y; Narimatsu H; Kitajima M
    Transplantation; 2008 Feb; 85(3):378-85. PubMed ID: 18322429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The glycosphingolipid composition of the placenta of a blood group P fetus delivered by a blood group Pk1 woman and analysis of the anti-globoside antibodies found in maternal serum.
    Hansson GC; Wazniowska K; Rock JA; Ness PM; Kickler TS; Shirey RS; Niebyl JR; Zopf D
    Arch Biochem Biophys; 1988 Jan; 260(1):168-76. PubMed ID: 3341739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of anti-HL-A-antibodies in cytotoxic pregnancy sera].
    Wolf E
    Z Immunitatsforsch Exp Klin Immunol; 1971 Aug; 142(2):148-65. PubMed ID: 4255078
    [No Abstract]   [Full Text] [Related]  

  • 10. Monoclonal antibody B2, a marker of neuroendocrine sympathoadrenal precursors, recognizes the Luke (LKE) antigen.
    Cooling L; Hwang D
    Transfusion; 2005 May; 45(5):709-16. PubMed ID: 15847659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Polyagglutination].
    Levene NA; Manny N; Buskila D
    Harefuah; 1986 Dec; 111(12):446-50. PubMed ID: 3557216
    [No Abstract]   [Full Text] [Related]  

  • 12. Histo-blood group antigens as allo- and autoantigens.
    Nydegger UE; Tevaearai H; Berdat P; Rieben R; Carrel T; Mohacsi P; Flegel WA
    Ann N Y Acad Sci; 2005 Jun; 1050():40-51. PubMed ID: 16014519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is a computer crossmatch in the absence of an immediate-spin antibody screen adequate for persons identified to be at increased risk of forming new blood group antibodies?
    Sandler SG; Abedalthagafi M; Langeberg A
    Transfusion; 2008 Oct; 48(10):2265-6. PubMed ID: 18928510
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antiglobulin antibodies in hematopoietic system diseases].
    Zupańska B
    Acta Haematol Pol; 1973; 4(4):315-20. PubMed ID: 4543973
    [No Abstract]   [Full Text] [Related]  

  • 15. Lectins in immunohematology.
    Bird GW
    Transfus Med Rev; 1989 Jan; 3(1):55-62. PubMed ID: 2520539
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prevention of the nonhemolytic type of reactions during the transfusion of blood and its components].
    Zaĭtseva GA; Zheleznova AI; Moiseeva VG; Aribzhanova IM; Vozgegova NP
    Gematol Transfuziol; 1984 Mar; 29(3):24-7. PubMed ID: 6714625
    [No Abstract]   [Full Text] [Related]  

  • 17. Red blood cell polyagglutination: clinical aspects.
    Beck ML
    Semin Hematol; 2000 Apr; 37(2):186-96. PubMed ID: 10791887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood groups and susceptibility to virus infection: new developments.
    Branch DR
    Curr Opin Hematol; 2010 Nov; 17(6):558-64. PubMed ID: 20739878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NOR polyagglutination and Sta glycophorin in one family: relation of NOR polyagglutination to terminal alpha-galactose residues and abnormal glycolipids.
    Kuśnierz-Alejska G; Duk M; Storry JR; Reid ME; Wiecek B; Seyfried H; Lisowska E
    Transfusion; 1999 Jan; 39(1):32-8. PubMed ID: 9920164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificities of human heterophilic Hanganutziu and Deicher (H-D) antibodies and avian antisera against H-D antigen-active glycosphingolipids.
    Fujii Y; Higashi H; Ikuta K; Kato S; Naiki M
    Mol Immunol; 1982 Jan; 19(1):87-94. PubMed ID: 6176858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.